Kraig Biocraft Laboratories, has achieved a major breakthrough in its genetic research, doubling the complexity and size of its spider silk gene insert package. This advancement is expected to enhance material performance, driving next-generation spider silk development.
By expanding the gene insert package, Kraig Labs aims to create stronger, more elastic, and more durable silk fibers. These improvements are critical for high-performance applications in defense, medical, and technical textile industries.
"Larger and more complex gene inserts could unlock superior material characteristics," said Kim Thompson, CEO of Kraig Labs. "This breakthrough strengthens our leadership in biomaterials innovation."
While pushing the boundaries in the lab, Kraig Labs is also advancing commercial production. The company remains on track to deliver commercial quantities of spider silk this year, targeting multiple market applications.
"Our team is balancing innovation and production to meet growing demand," said COO Jon Rice. "This will be a pivotal year for industry integration of spider silk."
With a dual focus on research and commercialization, Kraig Labs is positioning itself as a global leader in bioengineered spider silk. The company continues to drive innovation, aiming to transform the future of high-performance materials.
